These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Can antiarrhythmic agents be selected based on mechanism of action? Lau W; Newman D; Dorian P Drugs; 2000 Dec; 60(6):1315-28. PubMed ID: 11152014 [TBL] [Abstract][Full Text] [Related]
27. Clinical implications of new insights into mechanism of antiarrhythmic drug action. Meinertz T J Cardiovasc Pharmacol; 1992; 20 Suppl 2():S23-7. PubMed ID: 1279305 [TBL] [Abstract][Full Text] [Related]
28. Classification and pharmacology of antiarrhythmic drugs. Kowey PR; Marinchak RA; Rials SJ; Bharucha DB Am Heart J; 2000 Jul; 140(1):12-20. PubMed ID: 10874257 [TBL] [Abstract][Full Text] [Related]
29. Update on antiarrhythmic drugs in emergency medicine. Stapczynski JS Emerg Med Clin North Am; 1988 May; 6(2):289-315. PubMed ID: 2894981 [TBL] [Abstract][Full Text] [Related]
30. The 'Sicilian Gambit'. A new approach to the classification of antiarrhythmic drugs based on their actions on arrhythmogenic mechanisms. The Task Force of the Working Group on Arrhythmias of the European Society of Cardiology. Eur Heart J; 1991 Oct; 12(10):1112-31. PubMed ID: 1723682 [TBL] [Abstract][Full Text] [Related]
31. Potentially significant drug interactions of class III antiarrhythmic drugs. Yamreudeewong W; DeBisschop M; Martin LG; Lower DL Drug Saf; 2003; 26(6):421-38. PubMed ID: 12688833 [TBL] [Abstract][Full Text] [Related]
32. Evolution, mechanisms, and classification of antiarrhythmic drugs: focus on class III actions. Nattel S; Singh BN Am J Cardiol; 1999 Nov; 84(9A):11R-19R. PubMed ID: 10568655 [TBL] [Abstract][Full Text] [Related]
33. Assessment of the risk-benefit ratio for antiarrhythmic drug use. Campbell RW Drugs; 1988 Nov; 36(5):616-32. PubMed ID: 3063500 [TBL] [Abstract][Full Text] [Related]
36. Clinical approach to antiarrhythmic therapy in patients with ventricular arrhythmia. Reddy CP; Arnett JD J La State Med Soc; 1989 May; 141(5):45-8. PubMed ID: 2659710 [TBL] [Abstract][Full Text] [Related]
37. Specific drugs for specific ventricular arrhythmias: an evaluation of current therapy and the role of propafenone. Murtazam A; Campbell RW Eur Heart J; 1989 Sep; 10 Suppl E():41-7. PubMed ID: 2680501 [TBL] [Abstract][Full Text] [Related]
38. Natural Products as a Source of Antiarrhythmic Drugs. Bryzgalov AO; Tolstikova TG; Shults EE; Petrova KO Mini Rev Med Chem; 2018; 18(4):345-362. PubMed ID: 27823558 [TBL] [Abstract][Full Text] [Related]
40. Future perspectives in antiarrhythmic drugs. Harrison DC Ann N Y Acad Sci; 1984; 432():314-21. PubMed ID: 6596894 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]